To investigate if the association between low levels of glycine and high incidence of T2D could be a consequence of early disease processes of T2D, we assessed the genetically predicted effects of three T2D risk factors—elevated body mass index (BMI), reduced early-phase insulin secretion (IS) and IR—on levels of glycine. The gene discussed is INS; the disease is type 2 diabetes mellitus.